FDA's artificial intelligence is supposed to revolutionize drug approvals. It's making up ... - CNN
EU. Approach, Sector-specific, largely self-regulatory, Broad regulation with onus on AI developers to address risks ... risk AI systems (much like the ...
Read the original at CNN Business ↗
- Topics
- Regulation & PolicyHealthcare
- Mentions
- European UnionFDA
- Tracked via
- “AI Risks”